SLCH yields 2000000.00% · JNJ yields 2.13%● Live data
📍 SLCH pulled ahead of the other in Year 1
Combined, SLCH + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SLCH + JNJ for your $10,000?
Spotlight Capital Holdings, Inc., through its subsidiaries, provides maintenance, repair, and overhaul products and services for aircraft in the general aviation sector in Florida. It offers various services that include federal aviation administration (FAA) certified repair station, major and minor airframe repairs, annual inspections, computerized aircraft weight and balance, aircraft modifications and STC kit installations, routine maintenance/insurance and accident repairs, composite airframe repairs, and pre-purchase inspections/log book analysis. The company also provides oxygen service/nitrogen service, service parts, janitrol/southwind heater service/AD compliance inspections, dye/fluorescent penetrant inspection service, aircraft exterior and interior detailing services, ACES dynamic propeller balancing service, avionics installations and repairs, minor paint repairs and detailing, instrument panel upgrades and component installs, engine scanners and monitor installation, and EGT/CHT calibration, as well as engine maintenance, repair, and overhaul, including custom installations and refurbishment. In addition, it offers charter air services for both passengers and cargo from South Florida to the Bahamas with leased aircraft. The company was formerly known as AvStar Aviation Group, Inc. and changed its name to Spotlight Capital Holdings, Inc. in November 2014. The company is headquartered in Houston, Texas. Spotlight Capital Holdings, Inc. was founded in 1987 and is based in Houston, Texas.
Full SLCH Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.